Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) is scheduled to announce its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.19 per share for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.
Guardian Pharmacy Services Stock Performance
GRDN stock traded up $0.58 during mid-day trading on Tuesday, reaching $19.22. 208,304 shares of the stock traded hands, compared to its average volume of 143,129. Guardian Pharmacy Services has a 52 week low of $14.16 and a 52 week high of $20.10.
Wall Street Analyst Weigh In
A number of analysts have issued reports on GRDN shares. Raymond James assumed coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They issued an "outperform" rating and a $21.00 target price on the stock. Stephens started coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an "overweight" rating and a $21.00 target price on the stock. Finally, Truist Financial initiated coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They issued a "buy" rating and a $22.00 price target for the company.
Read Our Latest Stock Report on GRDN
Insider Transactions at Guardian Pharmacy Services
In other news, Director Thomas J. Salentine, Jr. bought 35,714 shares of the business's stock in a transaction that occurred on Friday, September 27th. The stock was acquired at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the completion of the purchase, the director now owns 35,714 shares of the company's stock, valued at $499,996. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
About Guardian Pharmacy Services
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Stories
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
